Risk factors for capillary leakage syndrome after bone marrow transplantation

被引:70
作者
Nurnberger, W [1 ]
Willers, R [1 ]
Burdach, S [1 ]
Gobel, U [1 ]
机构
[1] UNIV DUSSELDORF, CTR COMP, D-4000 DUSSELDORF, GERMANY
关键词
capillary leakage syndrome; cytokines endothelial damage; unrelated BMT; pediatric solid tumors;
D O I
10.1007/s002770050288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Age, hematopoietic growth factors, cyclosporin A, mode of bone marrow transplantation (BMT) tautologous, allogeneic-related, unrelated), and underlying disease were assessed as potential risk factors for capillary leakage syndrome (CLS) in 96 patients after BMT. CLS was defined as unexplained weight gain of >3% within 24 h and nonresponsiveness to furosemide. CLS occurred in 9/21 patients after unrelated compared with 2/33 after allogeneic-related BMT (p=0.0017) for hematopoietic disorders (n=54) and in 6/7 patients after allogeneic-related compared with 3/35 after autologous BMT (p=0.0001) for solid tumors (n=42). Hematopoietic growth factors and cyclosporin A were no significant risk factors on their own. We conclude that unrelated BMTs or high-intensity conditioning regimens used in combination with allogeneic-related BMT are the main risk factors for CLS.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 23 条
[1]   THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF CHILDREN WITH NEUROBLASTOMA STAGE-IV - THE GPO (GERMAN-PEDIATRIC-ONCOLOGY-SOCIETY) EXPERIENCE [J].
BERTHOLD, F ;
BURDACH, S ;
KREMENS, B ;
LAMPERT, F ;
NIETHAMMER, D ;
RIEHM, H ;
RITTER, J ;
TREUNER, J ;
UTSCH, S ;
ZIESCHANG, J .
KLINISCHE PADIATRIE, 1990, 202 (04) :262-269
[2]  
BLUME KG, 1987, BLOOD, V69, P1015
[3]   INCREASED FACTOR-VIII AS AN INDEX OF VASCULAR INJURY IN CYCLOSPORINE NEPHROTOXICITY [J].
BROWN, Z ;
NEILD, GH ;
WILLOUGHBY, JJ ;
SOMIA, NV ;
CAMERON, SJ .
TRANSPLANTATION, 1986, 42 (02) :150-153
[4]   MYELOABLATIVE RADIOCHEMOTHERAPY AND HEMATOPOIETIC STEM-CELL RESCUE IN POOR-PROGNOSIS EWINGS-SARCOMA [J].
BURDACH, S ;
JURGENS, H ;
PETERS, C ;
NURNBERGER, W ;
MAUZKORHOLZ, C ;
KORHOLZ, D ;
PAULUSSEN, M ;
PAPE, H ;
DILLOO, D ;
KOSCIELNIAK, E ;
GADNER, H ;
GOBEL, U .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1482-1488
[5]  
BURDACH S, 1994, ACTA MED AUSTRAI S44, V21, P7
[6]  
CLIFT RA, 1990, BLOOD, V76, P1867
[7]  
COTRAN RS, 1988, J IMMUNOL, V140, P1883
[8]  
FUNKE I, 1994, ANN HEMATOL, V68, P49
[9]   BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA - A SURVEY OF THE EUROPEAN-GROUP-FOR-BONE-MARROW-TRANSPLANTATION (EGBMT) [J].
GLUCKMAN, E ;
BARRETT, AJ ;
ARCESE, W ;
DEVERGIE, A ;
DEGOULET, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 49 (02) :165-173
[10]  
GORIN NC, 1992, BLOOD, V80, P1149